Target intelligence / Profile preview

Hematopoietic stem cell function

Molecular classification
Biological process, Physiological phenomenon
01

Overview

Hematopoietic stem cell (HSC) function refers to the fundamental biological processes of self-renewal and multi-lineage differentiation that maintain the blood and immune systems throughout an organism's life [NIH, 2016]. These cells reside in specialized bone marrow niches where they remain primarily quiescent but can rapidly proliferate and differentiate in response to physiological stressors like hemorrhage or infection [Nature Reviews Molecular Cell Biology, 2012]. Proper HSC function is vital for hematologic homeostasis, and its impairment is linked to various diseases, including bone marrow failure syndromes and hematologic malignancies such as leukemia [Hematology/Oncology Clinics, 2017]. While 'function' itself is not a singular molecular target like a receptor or enzyme, it is the primary physiological endpoint for numerous therapeutic interventions, such as those using G-CSF (Filgrastim) or Plerixafor to mobilize cells for transplantation [FDA Label, 2008]. Therapeutic strategies often focus on modulating signaling pathways or niche interactions to enhance HSC expansion or protect the stem cell pool from damage during intensive chemotherapy [Cell Stem Cell, 2014]. Understanding the molecular drivers of HSC function, such as the CXCR4/SDF-1 axis, allows for the development of drugs that can precisely control stem cell behavior for clinical benefit [Blood, 2015].

Other names
HematopoiesisHSC self-renewalHSC differentiationHSC homeostasisHematopoietic stem cell maintenance
02

Mechanism of action

Pharmacological agents do not target 'function' directly as a molecule; instead, they modulate it by interacting with specific receptors (e.g., CXCR4, G-CSFR) or signaling pathways (e.g., TPO signaling) to trigger stem cell mobilization, proliferation, or protection [FDA Label, 2008; Nature Reviews Molecular Cell Biology, 2012].

03

Biological functions

HematopoiesisCell self-renewalCell differentiationStem cell niche maintenanceMultipotency
04

Disease associations

Acute myeloid leukemiaMyelodysplastic syndromesAplastic anemiaFanconi anemiaBone marrow failure
05

Safety considerations

Stem cell exhaustionLeukemogenesisSplenic rupture (associated with mobilization agents)Graft-versus-host diseaseMyelosuppression
06

Interacting drugs

Filgrastim

4 more in the full profile.

07

Biomarkers

CD34 expressionCD38 negativityCD133 expressionALDH activityLineage-negative (Lin-) phenotype

Beyond the preview

Go deeper on Hematopoietic stem cell function.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hematopoietic stem cell function.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call